Ask AI
ProCE Banner Activity

HIV Care in 2025: From Daily Pills to Personalized, Long-Acting Care

Clinical Thought

Recent advances in HIV care have been nothing short of transformative. Read on to learn how the conversation has shifted from “Can we maintain viral suppression?” to “How can we make HIV care simpler, more durable, and more equitable?”

Released: November 21, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Jean-Michel Molina, MD, PhD: consultant/advisor/speaker: AstraZeneca, Gilead, Merck, ViiV, Zydus.